McIlrath & Eck’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.3K Buy
+51
New +$3.71K ﹤0.01% 790

Other funds holding PTCT

McIlrath & Eck's PTCT Position: Q3 2026 in Review

McIlrath & Eck opened a new position in PTC Therapeutics (PTCT) in Q3 2026: 51 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #790 among its holdings.

361 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

  • McIlrath & Eck held 51 shares of PTC Therapeutics worth $3.3K as of Q3 2026.
  • PTC Therapeutics was a new McIlrath & Eck position in Q3 2026.
  • PTC Therapeutics made up ﹤0.01% of McIlrath & Eck's portfolio in Q3 2026, its #790 holding.
  • 361 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on McIlrath & Eck's 13F filing for Q3 2026, filed 17 Nov 2026.